Shift Bioscience is a biotechnology company focused on reversing aging by cell rejuvenation. The company combines cutting-edge cell biology with machine learning to develop therapies that reduce cellular age without changing cell identity, leveraging AI-driven platforms and single-cell aging clocks to accelerate research. Headquartered in Cambridge, United Kingdom, with a computational group based in Toronto, Canada, Shift aims to create safer cell rejuvenation therapies targeting age-related diseases such as hearing loss and other age-associated conditions.
No recent news for this company.
No recent deals for this company.